Marco Colizzi

5.2k total citations · 2 hit papers
92 papers, 3.2k citations indexed

About

Marco Colizzi is a scholar working on Pharmacology, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Marco Colizzi has authored 92 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pharmacology, 34 papers in Psychiatry and Mental health and 32 papers in Clinical Psychology. Recurrent topics in Marco Colizzi's work include Cannabis and Cannabinoid Research (35 papers), COVID-19 and Mental Health (13 papers) and Autism Spectrum Disorder Research (12 papers). Marco Colizzi is often cited by papers focused on Cannabis and Cannabinoid Research (35 papers), COVID-19 and Mental Health (13 papers) and Autism Spectrum Disorder Research (12 papers). Marco Colizzi collaborates with scholars based in United Kingdom, Italy and Netherlands. Marco Colizzi's co-authors include Sagnik Bhattacharyya, Rosalia Costa, Mirella Ruggeri, Antonio Lasalvia, Leonardo Zoccante, Orlando Todarello, Marco Luigi Ciceri, Chiara Bovo, Philip McGuire and Polly Carmichael and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neuroscience & Biobehavioral Reviews and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Marco Colizzi

84 papers receiving 3.1k citations

Hit Papers

Psychosocial and Behavioral Impact of COVID-19 in Autism ... 2020 2026 2022 2024 2020 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Colizzi United Kingdom 28 1.3k 931 778 658 646 92 3.2k
Tabea Schoeler United Kingdom 24 640 0.5× 690 0.7× 386 0.5× 592 0.9× 266 0.4× 44 2.3k
Melissa M. Norberg Australia 30 1.7k 1.3× 878 0.9× 314 0.4× 315 0.5× 760 1.2× 111 3.2k
Guillaume Vaïva France 31 1.7k 1.3× 415 0.4× 619 0.8× 1.0k 1.6× 480 0.7× 208 3.5k
Adriana Feder United States 38 3.3k 2.5× 1.3k 1.3× 824 1.1× 813 1.2× 549 0.8× 89 6.2k
Carlos Roncero Spain 30 806 0.6× 427 0.5× 311 0.4× 922 1.4× 328 0.5× 207 3.0k
Christian J. Hopfer United States 40 1.1k 0.9× 1.1k 1.2× 304 0.4× 495 0.8× 371 0.6× 115 4.5k
Michael P. Hengartner Switzerland 34 1.5k 1.2× 521 0.6× 653 0.8× 840 1.3× 364 0.6× 147 3.5k
Michael C. Neale United States 18 1.6k 1.2× 412 0.4× 609 0.8× 582 0.9× 426 0.7× 25 4.4k
Michael M. Vanyukov United States 35 2.2k 1.7× 511 0.5× 480 0.6× 843 1.3× 521 0.8× 110 4.7k
Andrea Pfennig Germany 35 1.2k 0.9× 792 0.9× 626 0.8× 2.5k 3.7× 731 1.1× 148 4.9k

Countries citing papers authored by Marco Colizzi

Since Specialization
Citations

This map shows the geographic impact of Marco Colizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Colizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Colizzi more than expected).

Fields of papers citing papers by Marco Colizzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Colizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Colizzi. The network helps show where Marco Colizzi may publish in the future.

Co-authorship network of co-authors of Marco Colizzi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Colizzi. A scholar is included among the top collaborators of Marco Colizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Colizzi. Marco Colizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiappinotto, Stefania, Maddalena Peghin, Carlo Tascini, et al.. (2025). Post-COVID-19 Syndrome as Described by Patients: A Qualitative Study. Healthcare. 13(7). 757–757.
4.
Palagini, Laura, Mario Miniati, Lorenza Driul, et al.. (2024). Prenatal insomnia disorder may predict concurrent and postpartum psychopathology: A longitudinal study. Journal of Sleep Research. 33(6). e14202–e14202.
6.
Colizzi, Marco, Carla Comacchio, Maria De Martino, et al.. (2024). COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes. Irish Journal of Psychological Medicine. 41(3). 276–283. 5 indexed citations
7.
Comacchio, Carla, et al.. (2024). Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populations. Brain Behavior & Immunity - Health. 43. 100927–100927. 1 indexed citations
8.
Marin, Dario, et al.. (2023). Pediatric emergency department mental health assessments in the 2 years following the COVID-19 outbreak reveal higher vulnerability for eating disorder and suicide risk. Journal of Affective Disorders Reports. 15. 100687–100687. 1 indexed citations
9.
Garzitto, Marco, et al.. (2023). Changes in Revolving-Door Mental Health Hospitalizations during the COVID-19 Pandemic: A 5-Year Chart Review Study. Journal of Clinical Medicine. 12(7). 2681–2681. 3 indexed citations
10.
Palese, Alvisa, Stefania Chiappinotto, Maddalena Peghin, et al.. (2023). Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years. Health Research Policy and Systems. 21(1). 111–111. 4 indexed citations
11.
Palese, Alvisa, Valentina Bressan, Stefania Chiappinotto, et al.. (2023). Using Metaphors to Understand Suffering in COVID-19 Survivors: A Two Time-Point Observational Follow-Up Study. International Journal of Environmental Research and Public Health. 20(2). 1390–1390. 2 indexed citations
13.
Colizzi, Marco, Maddalena Peghin, Maria De Martino, et al.. (2023). COVID-19 Survivors Are Still in Need of Neuropsychiatric Support Two Years after Infection. Brain Sciences. 13(7). 1034–1034. 2 indexed citations
14.
Garzitto, Marco, et al.. (2023). Mentalization in young patients undergoing opioid agonist treatment: Implications for clinical management. Addictive Behaviors Reports. 17. 100497–100497. 2 indexed citations
15.
Bhattacharyya, Sagnik, Tabea Schoeler, Marta Di Forti, et al.. (2023). Stressful life events and relapse of psychosis: analysis of causal association in a 2-year prospective observational cohort of individuals with first-episode psychosis in the UK. The Lancet Psychiatry. 10(6). 414–425. 12 indexed citations
16.
Colizzi, Marco, et al.. (2023). Where Do Neurodevelopmental Disorders Go? Casting the Eye Away from Childhood towards Adulthood. Healthcare. 11(7). 1015–1015. 31 indexed citations
17.
Comacchio, Carla, Marco Garzitto, Rita Bianchi, et al.. (2023). Psychological factors associated with vaccination hesitancy: an observational study of patients hospitalized for COVID-19 in a later phase of the pandemic in Italy. Frontiers in Psychiatry. 14. 1272959–1272959.
18.
Colizzi, Marco, et al.. (2020). Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report. Brain Behavior & Immunity - Health. 5. 100073–100073. 107 indexed citations
19.
Rodríguez, Victoria, Olesya Ajnakina, Simona A. Stilo, et al.. (2018). Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study. Psychological Medicine. 49(13). 2256–2266. 11 indexed citations
20.
Colizzi, Marco, Conrad Iyegbe, John Powell, et al.. (2015). Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case–control study. Schizophrenia. 1(1). 15025–15025. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026